---
title: "Ingenol Mebutate - Actinic Keratosis"
sidebar: mydoc_sidebar
permalink: db05013-mesh-d055623-1.html
toc: false 
---


Path ID: `DB05013_MESH_D055623_1`
{% include image.html url="images/db05013-mesh-d055623-1.png" file="db05013-mesh-d055623-1.png" alt="db05013-mesh-d055623-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C486592 | Ingenol mebutate | Drug |
| UniProt:Q05655 | Protein kinase C delta type | Protein |
| GO:0004697 | Protein kinase C activity | MolecularActivity |
| UniProt:P17252 | Protein kinase C alpha type | Protein |
| GO:0070265 | Necrotic cell death | BiologicalProcess |
| GO:0001788 | Antibody-dependent cellular cytotoxicity | BiologicalProcess |
| MESH:D055623 | Actinic keratosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ingenol Mebutate | INCREASES ACTIVITY OF | Protein Kinase C Delta Type |
| Protein Kinase C Delta Type | POSITIVELY CORRELATED WITH | Protein Kinase C Activity |
| Ingenol Mebutate | INCREASES ACTIVITY OF | Protein Kinase C Alpha Type |
| Protein Kinase C Alpha Type | POSITIVELY CORRELATED WITH | Protein Kinase C Activity |
| Protein Kinase C Activity | POSITIVELY REGULATES | Necrotic Cell Death |
| Protein Kinase C Activity | POSITIVELY REGULATES | Antibody-Dependent Cellular Cytotoxicity |
| Necrotic Cell Death | TREATS | Actinic Keratosis |
| Antibody-Dependent Cellular Cytotoxicity | TREATS | Actinic Keratosis |
|---------|-----------|---------|

Comment: The exact mechanism of action of ingenol mebutate in actinic keratosis is unknown.

Reference: 
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257954/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257954/)
  - [https://en.wikipedia.org/wiki/Actinic_keratosis](https://en.wikipedia.org/wiki/Actinic_keratosis)
  - [https://go.drugbank.com/drugs/DB05013](https://go.drugbank.com/drugs/DB05013)
